SCHEMBL2733810

SCHEMBL2733810

COc1ccc(-c2c3cc(F)c(F)cc3c(-c3c(F)c(F)c(C(F)(F)F)c(F)c3F)c3c(F)cccc23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP1 P22413 2/20 0.40
ACHE P22303 1/20 0.36
MAOB P27338 1/20 0.35
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
ABL1 P00519 1/20 0.34
ABCB1 P08183 1/20 0.34
BCR P11274 1/20 0.34
SYK P43405 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
ENPP3 O14638 1/20 0.33
ALOX5 P09917 1/20 0.32
NR1H4 Q96RI1 1/20 0.32
ACP1 P24666 1/20 0.32
CYP1A2 P05177 1/20 0.32
NT5E P21589 1/20 0.32
PGR P06401 1/20 0.32
AR P10275 1/20 0.32
MAPT P10636 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12086106 0.95 ENPP1 (0.40) ENPP1ACHEMAOBCYP11B1CYP11B2
SCHEMBL12086166 0.93 ENPP1 (0.41) ENPP1ACHEMAOBCYP11B1CYP11B2
SCHEMBL12086128 0.91 ENPP1 (0.41) ENPP1ACHEMAOBCYP11B1CYP11B2
SCHEMBL2710211 0.90 ACHE (0.41) ENPP1ACHEMAOBABL1ABCB1
SCHEMBL12086238 0.89 ENPP1 (0.40) ENPP1ACHEMAOBCYP11B1CYP11B2
SCHEMBL2727015 0.88 ENPP1 (0.41) ENPP1ACHEMAOBCYP11B1CYP11B2
SCHEMBL2710301 0.88 ENPP1 (0.41) ENPP1ACHEMAOBCYP11B1CYP11B2
SCHEMBL2712788 0.88 ACHE (0.42) ENPP1ACHEMAOBCYP11B1CYP11B2
SCHEMBL12086104 0.87 GRM8 (0.32) ENPP1CYP1A2
SCHEMBL2712158 0.87 GRM8 (0.32) ENPP1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
EP-2445987-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS Cyalume Technologies, Inc (US) 2012-05-02 EP disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed
WO-2010151654-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECHNOLOGIES, INC. (US) 2010-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYP2F1, FLAD1, AFF1 ENPP1 2458/4885ACHE 187/4885MAOB 67/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.